StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 15 Feb 2024 17:50:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Thu, 15 Feb 2024 17:50:00 -0500 CRPOF CZO O.00985549 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Thu, 15 Feb 2024 17:50:00 -0500 CRPOF CZO O.00985549 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Thu, 15 Feb 2024 17:50:00 -0500 CRPOF CZO O.00985549 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Thu, 15 Feb 2024 17:50:00 -0500 CRPOF CZO O.00985549 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Thu, 15 Feb 2024 17:50:00 -0500 CRPOF CZO O.00985549 Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Announces+the+Mailing+of+Meeting+Materials+in+Connection+With+the+Special+Meeting+of+Securityholders+to+Approve+Merger+With+Aeterna+Zentaris/22790364.html Thu, 15 Feb 2024 17:50:00 -0500 CRPOF CZO O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Initiates+Phase+1-2a+Study+Assessing+Its+Flagship+Product+Avenanthramides+for+Potential+Applications+in+Inflammation+Based+Diseases/22454880.html Mon, 27 Nov 2023 09:15:00 -0500 A.36078215 CRPOF CZO O.00783833 O.00985549 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Press+Releases/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287 Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html for the full story. http://www.streetinsider.com/Globe+Newswire/Ceapro+Inc.+Appoints+Michel+Regnier+as+Senior+Vice+President%2C+Technical+Operations/21563439.html Thu, 27 Apr 2023 08:05:00 -0500 A.07336327 A.36078215 CRPOF CZO O.00783833 O.00985549 O.01077287